Biom’up present at the 8 th Strategic Council of Health Industries hosted by France’s Prime Minister

  • An illustration of Biom’up’s first achievements and growing position in international markets
  • Significant growth of the number of U.S. hospitals undergoing a medical-economic evaluation of HEMOBLASTTM Bellows
  • A strengthened sales force in the United States

Biom’up press release

ALL PRESS RELEASE

Caution: Federal law restricts this device to sale on or by the order of a physician. The trademark of HEMOBLAST™ Bellows and SPOT GRADE™ are the property of Biom’up. The trademarks of the products listed herein are trademarks of their respective manufacturer. Please refer to the Instructions for Use accompanying each device for further information. The presentation contains pictures owned by third party and remains their property.
E-MR-318-V1
HEMOBLAST™ Bellows Hemostatic Agent [instructions for use: E-MR-217-V6]